Abstract
Systemic Epstein-Barr virus (EBV)-positive T-cell lymphoproliferative disease of childhood is a rare disease and has a very fulminant clinical course with high mortality. A 21-month-old female patient was referred to our hospital with a 1 week history of fever and was subsequently diagnosed with systemic Epstein-Barr virus-positive T-cell lymphoproliferative disease of childhood. After starting treatment with dexamethasone, she showed early defervescence and improvement of laboratory parameters, and has remained disease-free after stopping steroid treatment, although longer follow-up is necessary. Our report underscores the possibility that this disease entity may be heterogenous in terms of prognosis.
Original language | English |
---|---|
Pages (from-to) | e497-e500 |
Journal | Journal of Pediatric Hematology/Oncology |
Volume | 39 |
Issue number | 8 |
DOIs | |
State | Published - 2017 |
Bibliographical note
Publisher Copyright:© 2017 Wolters Kluwer Health, Inc.
Keywords
- childhood
- EBV
- lymphoproliferative disease
- steroid
- T cells